Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

83 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase II randomized trial comparing metronomic anthracycline-containing chemotherapy versus standard schedule in untreated HER2 negative advanced breast cancer: activity and quality of life results of the GOIM 21003 trial.
Orlando L, Maiello E, Orditura M, Diana A, Antoniol G, Morritti MG, Aieta M, Ciccarese M, Pisconti S, Bordonaro R, Russo A, Febbraro A, Schiavone P, Quaranta A, Caliolo C, Loparco D, Cinefra M, Colucci G, Cinieri S; Gruppo Oncologico dell’Italia Meridionale (GOIM). Orlando L, et al. Among authors: schiavone p. Breast. 2024 Jun;75:103725. doi: 10.1016/j.breast.2024.103725. Epub 2024 Apr 5. Breast. 2024. PMID: 38615483 Free PMC article. Clinical Trial.
Metronomic oral chemotherapy with cyclophosphamide plus capecitabine combined with trastuzumab (HEX) as first line therapy of HER-2 positive advanced breast cancer: A phase II trial of the Gruppo Oncologico Italia Meridionale (GOIM).
Orlando L, Lorusso V, Giotta F, Di Maio M, Schiavone P, Fedele P, Quaranta A, Caliolo C, Ciccarese M, Cinefra M, Romito S, Pisconti S, Prete SD, Aieta M, Rizzi D, Maiello E, Colucci G, Cinieri S. Orlando L, et al. Among authors: schiavone p. Breast. 2020 Oct;53:18-22. doi: 10.1016/j.breast.2020.06.002. Epub 2020 Jun 5. Breast. 2020. PMID: 32540553 Free PMC article. Clinical Trial.
A multicenter phase II trial of nab-paclitaxel and capecitabine in HER-2 negative and triple- negative advanced breast cancer: Could be an old regimen a valid approach to a changing disease?
Ciccarese M, Orlando L, Fedele P, Schiavone P, Maiello E, Cilenti G, Aieta M, Bozza G, Forcignanò R, Febbraro A, Bordonaro R, Romito S, Rinaldi A, Borsellino N, Riccardi F, Pisconti S, Lorusso V, Colucci G, Surico G, Saracino V, Cinieri S; GOIM (Gruppo Oncologico dell’Italia Meridionale). Ciccarese M, et al. Among authors: schiavone p. Breast J. 2020 Sep;26(9):1857-1859. doi: 10.1111/tbj.13856. Epub 2020 May 20. Breast J. 2020. PMID: 32436244 Clinical Trial. No abstract available.
Genistein: the future of prevention and treatment of breast cancer?
Orlando L, Schiavone P, Cinieri S. Orlando L, et al. Among authors: schiavone p. Cancer Biol Ther. 2011 May 15;11(10):918-20. doi: 10.4161/cbt.11.10.15493. Epub 2011 May 15. Cancer Biol Ther. 2011. PMID: 21455031 Free article. No abstract available.
Panitumumab after progression on cetuximab in KRAS wild-type metastatic colorectal cancer patients: a single institution experience.
Marino A, Caliolo C, Sponziello F, Nacci A, Quaranta A, Mazzoni E, Lutrino SE, Rizzo P, Calvani N, Orlando L, Schiavone P, Fedele P, D'Amico M, Chetrì MC, Cinefra M, Ferrara P, Cinieri S. Marino A, et al. Among authors: schiavone p. Tumori. 2015 Sep-Oct;101(5):524-8. doi: 10.5301/tj.5000356. Epub 2015 May 25. Tumori. 2015. PMID: 26045117
83 results